Healthy Extracts (HYEX) Long-Term Deferred Tax (2015 - 2016)
Healthy Extracts' (HYEX) quarterly Long-Term Deferred Tax came in at $408700.0 in Q4 2016, up 154.17% year-on-year from $160800.0 in Q1 2016, and up 154.17% quarter-over-quarter from $160800.0 in Q4 2015.
Healthy Extracts (HYEX) Long-Term Deferred Tax (2015 - 2016) Analysis & Trends
Healthy Extracts' Long-Term Deferred Tax history runs 2 years deep, the most recent figure standing at $408700.0 for Q4 2016.
- On a quarterly basis, Long-Term Deferred Tax rose 154.17% year-over-year to $408700.0 in Q4 2016; TTM through Dec 2016 was $408700.0, a 154.17% increase from a year earlier, with the FY2016 full-year figure at $408700.0, up 154.17% from the prior year.
- Long-Term Deferred Tax advanced to $408700.0 in Q4 2016 per HYEX's latest filing, from $160800.0 in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $408700.0 in Q4 2016 and bottomed at $160800.0 in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Healthy Extracts | 14.70 Mn | 14.56 Mn | 957,429.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 408,700.00 |
| Dec 31, 2015 | 160,800.00 |